Legend Historical Balance Sheet

LEGN Stock

USD 63.62 0.55 0.86%

Trend analysis of Legend BiotechCorp balance sheet accounts such as Cash and Equivalents of 739.4 M provides information on Legend BiotechCorp's total assets, liabilities, and equity, which is the actual value of Legend BiotechCorp to its prevalent stockholders. By breaking down trends over time using Legend BiotechCorp balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year. Financial Statement Analysis is much more than just reviewing and breaking down Legend BiotechCorp prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Legend BiotechCorp is a good buy for the upcoming year.

Check out Correlation Analysis to better understand how to build diversified portfolios. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.

Total Liabilities Total Assets

About Legend Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Legend BiotechCorp at a specified time, usually calculated after every quarter, six months, or one year. Legend BiotechCorp Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Legend BiotechCorp and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Legend currently owns. An asset can also be divided into two categories, current and non-current.

Legend BiotechCorp Balance Sheet Chart

Legend BiotechCorp Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Legend BiotechCorp uses and utilizes its capital. It also shows what exactly a company owns and owes.

Legend BiotechCorp Investments are very stable at the moment as compared to the past year. Legend BiotechCorp reported last year Investments of 186.87 Million. As of 1st of June 2023, Investments Current is likely to grow to about 201.6 M, while Total Assets are likely to drop about 1.2 B.

Total Assets Current Assets Shareholders Equity Attributable to Parent Total Liabilities

Total Assets

Total assets refers to the total amount of Legend BiotechCorp assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Legend BiotechCorp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; Investments; Goodwill and Intangible Assets; Property Plant and Equipment Net; Tax Assets and Trade and Non Trade Receivables.

Current Assets

Current assets of Legend BiotechCorp include cash, cash equivalents, short-term investments, accounts receivable, stock inventory and the portion of prepaid liabilities which will be paid within a year. Depending on the nature of the business, current assets can range from barrels of crude oil, to baked goods, to foreign currency. Current assets are important because they are the assets that are used to fund day-to-day operations of Legend BiotechCorp. The current portion of Total Assets; reported if a company operates a classified balance sheet that segments current and non-current assets.

Shareholders Equity Attributable to Parent

A principal component of the balance sheet; in addition to Total Liabilities and Total Assets; that represents the total of all stockholders' equity (deficit) items; net of receivables from officers; directors; owners; and affiliates of the entity which are attributable to the parent.

Total Liabilities

Deferred Income Tax is recorded on Legend BiotechCorp balance sheet and a result of income already earned and recognized for accounting, but not tax, purposes. Also, differences between tax laws and accounting methods can result in a temporary difference in the amount of income tax payable by a company. This difference is recorded on Legend BiotechCorp books as deferred income tax. Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Principal components are Total Debt; Deferred Revenue; Trade and Non Trade Payables; Deposit Liabilities; and Tax Liabilities.

Most accounts from Legend BiotechCorp's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Legend BiotechCorp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.Legend BiotechCorp Investments are very stable at the moment as compared to the past year. Legend BiotechCorp reported last year Investments of 186.87 Million. As of 1st of June 2023, Investments Current is likely to grow to about 201.6 M, while Total Assets are likely to drop about 1.2 B.

	2020	2021	2022	2023 (projected)
Current Assets	592.86 M	949.85 M	1.1 B	946.22 M
Total Assets	721.01 M	1.12 B	1.33 B	1.15 B

Current Assets Total Assets

Legend BiotechCorp balance sheet Correlations

	Total Assets	Current Assets	Assets Non Current	Cash and Equivalents	Total Debt	Debt Current	Debt Non Current	Deferred Revenue	Goodwill and Intangible Assets	Inventory	Investments	Investments Current	Investments Non Current	Total Liabilities	Current Liabilities	Liabilities Non Current	Trade and Non Trade Payables	Property Plant and Equipment Net	Trade and Non Trade Receivables	Tax Assets	Tax Liabilities
Total Assets		1.0	0.98	0.99	0.91	0.84	0.91	0.88	0.92	0.82	0.85	0.84	-0.79	0.63	0.96	-0.34	0.94	0.91	-0.2	-0.79	-0.72
Current Assets	1.0		0.98	0.99	0.9	0.83	0.9	0.88	0.93	0.81	0.83	0.83	-0.78	0.61	0.95	-0.36	0.94	0.92	-0.18	-0.78	-0.73
Assets Non Current	0.98	0.98		0.94	0.96	0.9	0.96	0.91	0.84	0.9	0.92	0.92	-0.88	0.75	0.99	-0.2	0.95	0.87	-0.35	-0.88	-0.67
Cash and Equivalents	0.99	0.99	0.94		0.86	0.79	0.86	0.86	0.97	0.74	0.77	0.76	-0.7	0.52	0.91	-0.44	0.92	0.94	-0.07	-0.7	-0.78
Total Debt	0.91	0.9	0.96	0.86		0.94	1.0	0.94	0.74	0.97	0.98	0.98	-0.96	0.82	0.97	-0.12	0.93	0.82	-0.54	-0.96	-0.65
Debt Current	0.84	0.83	0.9	0.79	0.94		0.94	0.98	0.71	0.97	0.95	0.95	-0.96	0.89	0.87	0.13	0.94	0.85	-0.43	-0.96	-0.74
Debt Non Current	0.91	0.9	0.96	0.86	1.0	0.94		0.94	0.74	0.97	0.98	0.98	-0.95	0.81	0.97	-0.12	0.93	0.82	-0.54	-0.95	-0.65
Deferred Revenue	0.88	0.88	0.91	0.86	0.94	0.98	0.94		0.8	0.93	0.92	0.92	-0.91	0.8	0.87	0.0	0.98	0.93	-0.33	-0.91	-0.84
Goodwill and Intangible Assets	0.92	0.93	0.84	0.97	0.74	0.71	0.74	0.8		0.61	0.63	0.62	-0.56	0.37	0.78	-0.5	0.87	0.95	0.15	-0.56	-0.86
Inventory	0.82	0.81	0.9	0.74	0.97	0.97	0.97	0.93	0.61		0.99	1.0	-1.0	0.93	0.91	0.14	0.89	0.75	-0.6	-1.0	-0.59
Investments	0.85	0.83	0.92	0.77	0.98	0.95	0.98	0.92	0.63	0.99		1.0	-0.99	0.9	0.93	0.05	0.9	0.75	-0.63	-0.99	-0.57
Investments Current	0.84	0.83	0.92	0.76	0.98	0.95	0.98	0.92	0.62	1.0	1.0		-0.99	0.91	0.93	0.07	0.89	0.74	-0.63	-0.99	-0.56
Investments Non Current	-0.79	-0.78	-0.88	-0.7	-0.96	-0.96	-0.95	-0.91	-0.56	-1.0	-0.99	-0.99		-0.95	-0.89	-0.18	-0.87	-0.71	0.65	1.0	0.54
Total Liabilities	0.63	0.61	0.75	0.52	0.82	0.89	0.81	0.8	0.37	0.93	0.9	0.91	-0.95		0.75	0.47	0.75	0.56	-0.64	-0.95	-0.41
Current Liabilities	0.96	0.95	0.99	0.91	0.97	0.87	0.97	0.87	0.78	0.91	0.93	0.93	-0.89	0.75		-0.22	0.92	0.81	-0.46	-0.89	-0.58
Liabilities Non Current	-0.34	-0.36	-0.2	-0.44	-0.12	0.13	-0.12	0.0	-0.5	0.14	0.05	0.07	-0.18	0.47	-0.22		-0.11	-0.25	-0.3	-0.18	0.19
Trade and Non Trade Payables	0.94	0.94	0.95	0.92	0.93	0.94	0.93	0.98	0.87	0.89	0.9	0.89	-0.87	0.75	0.92	-0.11		0.96	-0.28	-0.87	-0.84
Property Plant and Equipment Net	0.91	0.92	0.87	0.94	0.82	0.85	0.82	0.93	0.95	0.75	0.75	0.74	-0.71	0.56	0.81	-0.25	0.96		0.0	-0.71	-0.94
Trade and Non Trade Receivables	-0.2	-0.18	-0.35	-0.07	-0.54	-0.43	-0.54	-0.33	0.15	-0.6	-0.63	-0.63	0.65	-0.64	-0.46	-0.3	-0.28	0.0		0.65	-0.14
Tax Assets	-0.79	-0.78	-0.88	-0.7	-0.96	-0.96	-0.95	-0.91	-0.56	-1.0	-0.99	-0.99	1.0	-0.95	-0.89	-0.18	-0.87	-0.71	0.65		0.54
Tax Liabilities	-0.72	-0.73	-0.67	-0.78	-0.65	-0.74	-0.65	-0.84	-0.86	-0.59	-0.57	-0.56	0.54	-0.41	-0.58	0.19	-0.84	-0.94	-0.14	0.54

Click cells to compare fundamentals

Legend BiotechCorp Account Relationship Matchups

Be your own money manager

Our tools can tell you how much better you can do entering a position in Legend BiotechCorp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Transformation Now

Price Transformation

Use Price Transformation models to analyze the depth of different equity instruments across global markets

All Next

Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Legend BiotechCorp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

Check out Correlation Analysis to better understand how to build diversified portfolios. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.

	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites

Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.14)

Revenue Per Share

0.639

Quarterly Revenue Growth

(0.12)

Return On Assets

(0.29)

Return On Equity

(0.96)

The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. Check out Correlation Analysis to better understand how to build diversified portfolios. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

Legend Historical Balance Sheet

About Legend Balance Sheet Analysis

Legend BiotechCorp Balance Sheet Chart

Total Assets

Current Assets

Shareholders Equity Attributable to Parent

Total Liabilities

Legend BiotechCorp balance sheet Correlations

Legend BiotechCorp Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Be your own money manager

Did you try this?

Run Price Transformation Now

Price Transformation

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Legend Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Current Assets	+ 1.0	Total Assets
Debt Non Current	+ 1.0	Total Debt
Investments Current	+ 1.0	Inventory
Investments Current	+ 1.0	Investments
Tax Assets	+ 1.0	Investments Non Current
Cash and Equivalents	+ 0.99	Total Assets

Tax Assets	- 1.0	Inventory
Investments Non Current	- 1.0	Inventory
Tax Assets	- 0.99	Investments Current
Investments Non Current	- 0.99	Investments Current
Tax Assets	- 0.99	Investments
Investments Non Current	- 0.99	Investments